0001209191-17-002976.txt : 20170109
0001209191-17-002976.hdr.sgml : 20170109
20170109171227
ACCESSION NUMBER: 0001209191-17-002976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170105
FILED AS OF DATE: 20170109
DATE AS OF CHANGE: 20170109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerulean Pharma Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204139823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-996-4300
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eliasof Scott
CENTRAL INDEX KEY: 0001688065
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 17518547
MAIL ADDRESS:
STREET 1: C/O CERULEAN PHARMA INC.
STREET 2: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-05
0
0001401914
Cerulean Pharma Inc.
CERU
0001688065
Eliasof Scott
C/O CERULEAN PHARMA INC.
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
0
1
0
0
SVP, Chief Scientific Officer
Stock Option (right to buy)
0.82
2017-01-05
4
A
0
60000
0.00
A
2027-01-04
Common Stock
60000
60000
D
Stock Option (right to buy)
0.82
2017-01-05
4
A
0
100000
0.00
A
2027-01-04
Common Stock
100000
100000
D
This option was granted on January 5, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017.
This option was granted on January 5, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019.
/s/ Alejandra Carvajal, as attorney-in-fact for Scott Eliasof
2017-01-09